---
title: "Biopharma Manufacturing Equipment Industry: Companies, KPIs & Risks"
description: "Biopharma manufacturing equipment makers supply bioreactors, filters, chromatography resins, single-use bags and process controls to drug producers."
canonical: https://www.getswoopr.com/stocks/industries/health-care/biopharma-manufacturing-equipment/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# Biopharma Manufacturing Equipment Industry

## Direct Answer

Biopharma manufacturing equipment makers supply bioreactors, filters, chromatography resins, single-use bags and process controls to drug producers. Revenue is mixed between systems and consumables that are reordered with every production run.

## Industry Overview

Biopharma Manufacturing Equipment sits within the health care sector. The first numbers to compare across companies here are consumables share of revenue, order backlog and book-to-bill and organic growth. The outside forces that move them are listed under Primary Macro Drivers.

## Key Industry Metrics

- **Consumables share of revenue**: Portion of sales from filters, resins and single-use bags reordered with each production run. A larger share means steadier repeat income, while systems sales swing more with customer capital budgets.
- **Order backlog and book-to-bill**: Backlog is orders accepted but not yet delivered; book-to-bill compares new orders with shipments. A ratio above one means orders are outpacing shipments, while below one suggests revenue may soften ahead.
- **Organic growth**: Sales growth excluding acquisitions and currency effects. Here it reflects customer production volumes and inventory cycles, so customer destocking can depress it even when end demand is healthy.
- **Gross margin**: Share of sales left after the production cost of equipment and consumables. Consumables tend to carry higher margins than systems, so mix shifts and pricing on single-use products move this measure.
- **Customer concentration**: Share of revenue coming from the largest drug producers. A high share means a delayed order or lost contract from one buyer can move results noticeably.

## Primary Macro Drivers

- **Biologic and cell-and-gene therapy production growth**: More biologic and cell-and-gene therapy batches mean more bags, filters and resins reordered per run, which feeds consumables share of revenue and organic growth.
- **Capacity buildouts by pharma and CDMOs**: New plants and expansions require bioreactors and process systems, which lift order backlog and book-to-bill ahead of recurring consumables revenue.
- **Inventory destocking cycles**: After customers stock up, they can run down inventory instead of reordering, which depresses sales for a few quarters even while production is healthy.
- **Biotech funding conditions**: Cash-constrained biotechs delay building or scaling manufacturing, so weak funding reduces equipment orders and slows consumables growth.

## Major Risks

- **Customer inventory swings**: When customers hold too much stock, they stop reordering until it is used; analysts watch book-to-bill and the gap between consumables sales and customer production activity.
- **Concentrated customer base**: A few large drugmakers account for much of the sales, so a lost contract or delayed project moves results; watch the customer concentration disclosure in filings.
- **Competition on single-use components**: Rivals' lower-priced single-use bags and filters can take reorders or push prices down; watch gross margin and consumables growth against peers.
- **Capital-equipment order delays**: Large equipment is bought with project budgets that can slip, so revenue moves from one quarter to the next; watch backlog age and cancellations.

## Industry Characteristics

| Characteristic | Profile |
| --- | --- |
| Cyclicality | Mixed |
| Capital Intensity | Medium |
| Regulatory Intensity | Medium |
| Industry Maturity | Growth |
| Geographic Importance | Global |

## Companies Associated with Biopharma Manufacturing Equipment

The SEC's Standard Industrial Classification has no code that describes biopharma manufacturing equipment as a group, so there is no complete list of its filers. The companies below come from Swoopr's SEC dataset and have operations in or next to the industry. Each is classified by the SEC under its own main business.

| Company | SEC classification | Revenue | Growth | Net margin | Year |
| --- | --- | --- | --- | --- | --- |
| [Thermo Fisher Scientific Inc.](https://www.getswoopr.com/stocks/companies/thermo-fisher-scientific/) | Measuring & Controlling Devices, Nec | $44.6 billion | 3.9% | 15.1% | FY 2025 |
| [Repligen Corp](https://www.getswoopr.com/stocks/companies/repligen-corporation/) | Biological Products, (No Diagnostic Substances) | $738 million | 16.4% | 6.6% | FY 2025 |

Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. Listing here describes a business relationship to the industry, not a recommendation. To find more companies, use the [company directory](https://www.getswoopr.com/stocks/companies/) and the [health care hub](https://www.getswoopr.com/stocks/industries/health-care/).

## Where to Go Next

The Biopharma Manufacturing Equipment guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.

### More in Health Care

- [Health Care sector overview](https://www.getswoopr.com/stocks/industries/health-care/)
- [Biosimilars](https://www.getswoopr.com/stocks/industries/health-care/biosimilars/)
- [Bioinformatics](https://www.getswoopr.com/stocks/industries/health-care/bioinformatics/)
- [Biotechnology](https://www.getswoopr.com/stocks/industries/health-care/biotechnology/)
- [Behavioral Health Providers](https://www.getswoopr.com/stocks/industries/health-care/behavioral-health-providers/)
- [Cardiometabolic Pharmaceuticals](https://www.getswoopr.com/stocks/industries/health-care/cardiometabolic-pharmaceuticals/)
- [Antibody Therapeutics](https://www.getswoopr.com/stocks/industries/health-care/antibody-therapeutics/)
- [Cardiovascular Devices](https://www.getswoopr.com/stocks/industries/health-care/cardiovascular-devices/)
- [Animal Health](https://www.getswoopr.com/stocks/industries/health-care/animal-health/)

### Put it to work

- [How to analyze a stock](https://www.getswoopr.com/stocks/how-to-analyze-a-stock/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)
- [Company research](https://www.getswoopr.com/stocks/companies/)
- [All industries](https://www.getswoopr.com/stocks/industries/)

## Frequently Asked Questions

What are the main KPIs for the Biopharma Manufacturing Equipment industry?

Key performance indicators for the Biopharma Manufacturing Equipment industry include: Consumables share of revenue, Order backlog and book-to-bill, Organic growth, Gross margin, Customer concentration. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.

How cyclical is the Biopharma Manufacturing Equipment industry?

The Biopharma Manufacturing Equipment industry exhibits mixed cyclicality characteristics. Some segments move with the broader economy while others maintain more stable demand, making stock selection within the group particularly important.

What are the biggest risks in the Biopharma Manufacturing Equipment industry?

The primary risks for Biopharma Manufacturing Equipment companies include: Customer inventory swings, Concentrated customer base, Competition on single-use components, Capital-equipment order delays. Investors should assess each company's exposure to these factors and its track record of navigating them.

**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**

Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).